Health Condition 1: L80- Vitiligo
Conditions
Interventions
Intervention1: 2 percent Crisaborole ointment: Total 40 patients will be divided randomly in 2 groups - 20 patients will be asked to use 2percent crisaborole
ointment on focal vitiligo patches for a
Sponsors
Dr Saoji Ojasvi Virendra
Eligibility
Inclusion criteria
Inclusion criteria: Patients who are willing to undergo topical therapy with their signed informed consent. The percentage of body surface area affected by vitiligo is less than 20 percent. Patients who did not take any vitiligo therapy for 2 months before the study.
Exclusion criteria
Exclusion criteria: Cases of post inflammatory hypopigmentation. Lesions involving mucosal area. Pregnant and lactating women. Allergy or hypersensitivity to PDE4 inhibitors or steroids. Known history of malignancy, immunodeficiency, cardiovascular diseases, impaired renal or liver functions. Patients with signs of skin atrophy. Patients lost to follow up after initial visits.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare effectiveness, safety and adverse effects of 2 percent Crisaborole versus 0.1 percent Mometasone Furoate Cream in vitiligo.Timepoint: outcome will be assessed/estimated i.e. at baseline, 4 weeks and 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Gopalakrishnan
Chettiand Hospital and Research Institute
Outcome results
None listed